What does the scientific evidence say about routine male circumcision?
Our take
Circumcision has documented medical benefits and documented surgical risks. There is no worldwide agreement that every infant should be circumcised.
Why we say this
WHO, 2007
Randomized trials found circumcision reduced heterosexual HIV acquisition for men in high-prevalence settings.
AAP, 2012
Associated with fewer infant urinary tract infections — and with bleeding, infection, and rare serious injury.
AAP policy, 2012
Concludes benefits outweigh risks but does not recommend universal infant circumcision.
This is not a claim of absolute truth. Read the whole story for more context.
as of July 31, 2026
Where the claims stand
This story tracks the scientific evidence regarding male circumcision, including potential medical benefits, risks, and areas of scientific disagreement. The evidence consists primarily of systematic reviews, randomized controlled trials, peer-reviewed research, and official guidance from medical organizations. Because circumcision is performed for medical, religious, cultural, and personal reasons, this story evaluates health claims separately from ethical or religious arguments.
We'll only notify you when something material changes.
Additional information
Status
as of July 31, 2026The medical literature on circumcision is extensive and has been reviewed by numerous professional organizations. There is broad agreement that circumcision provides some measurable medical benefits but carries surgical risks. However, medical organizations differ in how they weigh those benefits against the risks and ethical considerations, particularly regarding routine circumcision of infants who cannot provide consent.
Confidence — current state
Multiple randomized controlled trials and systematic reviews have found that male circumcision reduces the risk of heterosexual acquisition of HIV in high-prevalence settings and lowers the risk of some sexually transmitted infections, urinary tract infections during infancy, and penile cancer later in life. The procedure also carries immediate surgical risks such as bleeding, infection, pain, and, rarely, more serious complications. Medical organizations differ in their recommendations because they assign different weight to the magnitude of these benefits, the frequency of complications, cultural values, bodily autonomy, and the epidemiology of their populations. Scientific evidence can estimate medical risks and benefits but does not determine ethical questions regarding consent or cultural practice.
This is our best read given the published evidence we have reviewed — not a claim of absolute truth.
Open questions
How large are the lifetime medical benefits in countries with low HIV prevalence?
Most randomized trials demonstrating HIV reduction were conducted in regions with high heterosexual HIV transmission.
How should medical benefits be weighed against infant bodily autonomy?
This is primarily an ethical question informed by, but not answered by, scientific evidence.
How do complication rates vary by age, provider experience, and surgical technique?
Risk estimates differ across populations and clinical settings.
What would change our mind
- Large, independently replicated clinical studies demonstrating substantially different long-term health outcomes.
- Updated systematic reviews materially changing estimates of benefits or complications.
- New evidence demonstrating that existing randomized trials are substantially biased or not generalizable.
Claims & evidence
Each claim is tracked separately — not a single verdict.Randomized controlled trials have found that male circumcision reduces heterosexual acquisition of HIV among men in high-prevalence settings.
Evidence basis- Voluntary medical male circumcision for HIV prevention
WHO summarizes randomized controlled trials demonstrating reduced heterosexual HIV acquisition.
- Information for Providers Counseling Male Patients and Parents Regarding Male Circumcision
CDC summarizes randomized trial evidence that male circumcision reduces heterosexual HIV acquisition risk.
- Male circumcision for prevention of heterosexual acquisition of HIV by men
Cochrane systematic review of randomized trials on male circumcision and HIV prevention.
Male circumcision is associated with lower risks of infant urinary tract infections and some other medical conditions.
Evidence basis- Circumcision Policy Statement
AAP reviews evidence regarding urinary tract infections and other medical outcomes.
- Information for Providers Counseling Male Patients and Parents Regarding Male Circumcision
CDC counseling guidance discusses reduced risks of urinary tract infection and some other adverse health outcomes.
Male circumcision carries risks of surgical complications, including bleeding, infection, and, rarely, more serious injury.
Evidence basis- Circumcision Policy Statement
Professional guidance discusses expected complication rates and procedural risks.
- Voluntary medical male circumcision for HIV prevention
WHO discusses safety and adverse events associated with circumcision.
Medical organizations worldwide agree that routine infant circumcision should be universally recommended.
Evidence basis- Circumcision Policy Statement
AAP concludes benefits outweigh risks but stops short of recommending universal circumcision.
- Voluntary medical male circumcision for HIV prevention
WHO recommendations are targeted toward specific HIV epidemiological settings.
- Newborn male circumcision
CPS does not recommend the routine circumcision of every newborn male.
What this doesn’t establish
Claims commonly associated with this story that the available evidence does not establish. Confirming a narrow fact here is not confirmation of the broader narrative around it. As such, these claims are not included in the claims bar above.
Scientific evidence establishes that routine infant circumcision is ethically justified.
Evidence basis- Circumcision Policy Statement
Medical evidence informs ethical discussions but does not resolve questions of bodily autonomy and consent.
Because circumcision has documented medical benefits, the procedure carries no meaningful risks.
Evidence basis- Circumcision Policy Statement
The policy discusses both documented benefits and recognized procedural risks.
How we got here
6 updates · append-onlyCDC finalizes U.S. provider counseling information on male circumcision
CDC published finalized information for providers counseling patients and parents about male circumcision, HIV, STIs, and other health outcomes. The document summarizes benefits and risks to support informed decision-making and does not establish routine infant circumcision as a universal mandate.
What changed
- U.S. public-health counseling guidance: 2014 draft recommendations under comment CDC finalizes provider counseling information (2018/2019)
Canadian Paediatric Society declines to recommend routine newborn circumcision
After reviewing updated evidence on UTIs, STIs, and HIV, the Canadian Paediatric Society concluded it does not recommend routine circumcision of every newborn male — underscoring that major medical organizations weigh the same evidence differently for routine infant circumcision.
What changed
- Claim: global-medical-consensus-routine-infant-circumcision: disputed contradicted
- International pediatric guidance: U.S. AAP finds benefits outweigh risks without universal mandate CPS explicitly declines routine newborn recommendation
AAP publishes circumcision policy statement
The American Academy of Pediatrics reviewed benefits and risks of infant circumcision, concluding benefits outweigh risks but stopping short of a universal recommendation. The statement also discusses procedural complications such as bleeding and infection.
What changed
- U.S. pediatric guidance: Prior AAP statements 2012 AAP policy: benefits outweigh risks; no universal recommendation
Cochrane review confirms trial evidence on circumcision and HIV
A Cochrane systematic review of the three African randomized trials concluded that male circumcision reduces heterosexual HIV acquisition in men and reported low rates of surgical adverse events in the trial settings.
What changed
- Claim: circumcision-reduces-hiv-risk: supported corroborated
WHO and UNAIDS recommend male circumcision for HIV prevention in high-prevalence settings
After an expert consultation, WHO and UNAIDS recommended recognizing voluntary medical male circumcision as an additional HIV prevention intervention for men in settings with high heterosexual HIV prevalence and low circumcision rates — not as a universal infant recommendation.
What changed
- HIV prevention guidance: Trial evidence without WHO programme recommendation WHO/UNAIDS recommend VMMC in targeted high-prevalence settings
Three African RCTs establish circumcision reduces heterosexual HIV acquisition
Randomized trials in South Africa (Auvert et al., 2005), Kenya (Bailey et al., 2007), and Uganda (Gray et al., 2007) found that medical male circumcision reduced heterosexual HIV acquisition among men by roughly half in high-prevalence settings — the core trial evidence later cited by WHO, CDC, and Cochrane.
What changed
- HIV prevention evidence: Observational and ecological studies Three RCTs show ~50–60% risk reduction in high-prevalence settings
Help improve this story
Point us at a source, a mistake, or a framing problem. Sign in to submit — every submission is reviewed by a human before anything changes.
Confidence last reviewed July 31, 2026. Updates are append-only; nothing here is edited silently.
We'll only notify you when something material changes.